文献速递心脏核医学肿瘤 PET/CT

两阶段心脏PET与晚期钆增强MRI共配准方法:利用一体化PET/MR改善非缺血性心肌病评估

A two-stage cardiac PET and late gadolinium enhancement MRI co-registration method for improved assessment of non-ischemic cardiomyopathies using integrated PET/MR.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-01-15

研究提出两阶段心脏PET与晚期钆增强(LGE)MRI共配准方法,在一体化全身PET/MR系统上与一阶段直接配准及不配准比较,评估191层LGE图像和40个病灶。两阶段法配准评分和心肌SUV均显著高于不配准和一阶段法,LGE病灶平均SUV从2.51±2.09升至2.85±2.35(P<0.001)。作者认为该技术可能通过更好的图像共配准改善非缺血性心肌病的诊断准确性。

要点

  • 两阶段法配准评分4.93±0.89,高于不配准3.49±0.84和一阶段法4.23±0.81(P均<0.001)。
  • 两阶段法心肌SUV为3.87±2.56,高于不配准3.14±1.92和一阶段法3.32±2.16(P均<0.001)。
  • 两阶段共配准后LGE病灶平均SUV从2.51±2.09升至2.85±2.35(P<0.001)。

核心结论

  • 所提出的两阶段配准方法显著改善了一体化PET/MR成像中PET与LGE之间的共配准。
  • 该技术可能通过更好的图像共配准改善非缺血性心肌病的诊断准确性。

研究设计与样本

  • 研究在一体化全身PET/MR系统上提出两阶段心脏PET与LGE共配准方法,并与一阶段直接配准及不配准进行比较。
  • 共研究191层LGE图像和40个病灶。
  • 两名受过训练的核医学医师独立评估LGE与PET之间的位移以定性评价共配准质量。
  • 测量图像共配准前后正常心肌和LGE强化病灶的平均SUV变化,以定量评价共配准的准确性和价值。
  • 注册号为DF-2020-085,日期2020.04.30。

主要发现

  • 两阶段法配准评分4.93±0.89,高于不配准法3.49±0.84(P<0.001)和一阶段法4.23±0.81(P<0.001)。
  • 两阶段法心肌SUV为3.87±2.56,高于不配准法3.14±1.92(P<0.001)和一阶段法3.32±2.16(P<0.001)。
  • 两阶段共配准后LGE病灶平均SUV从2.51±2.09升至2.85±2.35(P<0.001)。

临床怎么用

  • 作者认为该两阶段共配准技术可能通过更好的图像共配准改善非缺血性心肌病的诊断准确性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Respiratory motion causes mismatches between PET images of the myocardium and the corresponding cardiac MR images in cardiac integrated PET/MR. The mismatch may affect the attenuation correction and the diagnosis of non-ischemic cardiomyopathies. In this study, we present a two-stage cardiac PET and MR late gadolinium enhancement (LGE) co-registration method, which seeks to improve diagnostic accuracy of non-ischemic cardiomyopathies via better image co-registration using an integrated whole-body PET/MR system. METHODS: The proposed PET and LGE two-stage co-registration method was evaluated through comparison with one-stage direct co-registration and no-registration. One hundred and ninety-one slices of LGE and forty lesions were studied. Two trained nuclear medicine physicians independently assessed the displacement between LGE and PET to qualitatively evaluate the co-registration quality. The changes of the mean SUV in the normal myocardium and the LGE-enhanced lesions before and after image co-registration were measured to quantitatively evaluate the accuracy and value of image co-registration. RESULTS: The two-stage method had an improved image registration score (4.93 ± 0.89) compared with the no-registration method (3.49 ± 0.84, p value < 0.001) and the single-stage method (4.23 ± 0.81, p value < 0.001). Furthermore, the two-stage method led to increased SUV value in the myocardium (3.87 ± 2.56) compared with the no-registration method (3.14 ± 1.92, p value < 0.001) and the single-stage method (3.32 ± 2.16, p value < 0.001). The mean SUV in the LGE lesion significantly increased from 2.51 ± 2.09 to 2.85 ± 2.35 (p value < 0.001) after the two-stage co-registration. CONCLUSION: The proposed two-stage registration method significantly improved the co-registration between PET and LGE in integrated PET/MR imaging. The technique may improve diagnostic accuracy of non-ischemic cardiomyopathies via better image co-registration. REGISTERED NO: DF-2020-085,2020.04.30.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Chen X, Wan Q, et al. A two-stage cardiac PET and late gadolinium enhancement MRI co-registration method for improved assessment of non-ischemic cardiomyopathies using integrated PET/MR. Eur J Nucl Med Mol Imaging. 2022. PMID: 35031812. doi:10.1007/s00259-022-05681-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。